Yoseph Shaaltiel

2018

In 2018, Yoseph Shaaltiel earned a total compensation of $433.4K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 8% decrease compared to previous year.

Compensation breakdown

Option Awards$60,575
Salary$288,719
Other$84,148
Total$433,442

Shaaltiel received $288.7K in salary, accounting for 67% of the total pay in 2018.

Shaaltiel also received $60.6K in option awards and $84.1K in other compensation.

Rankings

In 2018, Yoseph Shaaltiel's compensation ranked 12,320th out of 14,244 executives tracked by ExecPay. In other words, Shaaltiel earned more than 13.5% of executives.

ClassificationRankingPercentile
All
12,320
out of 14,244
14th
Division
Manufacturing
4,981
out of 5,759
14th
Major group
Chemicals And Allied Products
1,880
out of 2,122
11th
Industry group
Drugs
1,608
out of 1,811
11th
Industry
Biological Products, Except Diagnostic Substances
310
out of 339
9th

Pay ratio

Yoseph Shaaltiel's Pay$433,442
Median Employee's Pay$47,782
Pay Ratio

9

to 1

In 2018, the annual total compensation of Yoseph Shaaltiel was $433,442.

The annual total compensation of the median employee at Protalix BioTherapeutics was $47,782.

The ratio of Yoseph Shaaltiel's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on April 12, 2019.

Shaaltiel's colleagues

We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2018.

2018

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

2018

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2018

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2018

Yaron Naos

Protalix BioTherapeutics

Senior Vice President, Operations

News

You may also like